Company Filing History:
Years Active: 2016-2017
Title: The Innovations of Tao-Sheng Li
Introduction
Tao-Sheng Li is a prominent inventor based in Nanchang, China. He has made significant contributions to the field of stem cell research, particularly in maintaining genomic stability in cultured stem cells. With a total of 2 patents, his work is paving the way for advancements in cellular therapies.
Latest Patents
Li's latest patents focus on the maintenance of genomic stability in cultured stem cells. The first patent describes methods and compositions for generating therapeutic cells with a reduced incidence of karyotypic abnormalities. In this application, cardiac stem cells are cultured in antioxidant-supplemented media that lowers levels of reactive oxygen species while preserving DNA repair mechanisms. Additionally, physiological oxygen concentrations are utilized during culture to enhance stem cell proliferation, decrease cellular senescence, and improve genomic stability. The second patent mirrors the first, emphasizing the same innovative methods and compositions for maintaining genomic stability in cultured stem cells.
Career Highlights
Tao-Sheng Li is affiliated with Cedars-Sinai Medical Center, where he continues to advance his research in stem cell therapies. His work is crucial in developing methods that enhance the functionality of therapeutic cells, which can lead to improved treatment options for various medical conditions.
Collaborations
Li collaborates with Eduardo Marbán, a fellow researcher who shares his passion for stem cell innovation. Their partnership is instrumental in driving forward the research and application of stem cell therapies.
Conclusion
Tao-Sheng Li's contributions to stem cell research and his innovative patents are vital for the future of cellular therapies. His work not only enhances our understanding of genomic stability but also opens new avenues for therapeutic applications.